BRCA2 and breast cancer: Initial reports of comprehensive screening of all of the protein encoding exons of PALB2, identified no variants in 38 breast cancer families, where 22 families had a prior probability of greater than 10% of harboring a BRCA1 or BRCA2 mutation[10].